Laurus Labs Ltd.

BSE: 540222 | NSE: LAURUSLABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE947Q01028 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Laurus Labs Lt Laurus Labs Ltd. | BSE 954.50 -15.50 (-1.60%) | NSE 953.65 -16.70 (-1.72%) | Trade | Add

BSE Live

Oct 31, 16:01

954.50 -15.50 (-1.60%)

Volume

AVERAGE VOLUME

5-Day

188,713

10-Day

140,213

30-Day

136,439

70,633

Prev. Close

970.00
Open Price

970.50

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 31, 15:59

953.65 -16.70 (-1.72%)

Volume

AVERAGE VOLUME

5-Day

4,037,701

10-Day

3,056,956

30-Day

2,513,103

1,545,420

Prev. Close

970.35
Open Price

970.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
953.65 (768)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Laurus Labs (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	5,172.15	4,774.19	5,742.32	4,659.02	4,692.23
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	5,172.15	4,774.19	5,742.32	4,659.02	4,692.23
Total Operating Revenues	5,216.98	4,812.39	5,773.45	4,707.04	4,768.72
Other Income	65.10	47.42	15.95	13.48	27.32
Total Revenue	5,282.08	4,859.81	5,789.40	4,720.52	4,796.04
EXPENSES
Cost Of Materials Consumed	2,371.38	2,396.95	2,515.94	2,281.37	2,375.35
Purchase Of Stock-In Trade	105.36	110.92	155.71	145.81	96.23
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-13.55	-102.48	40.82	-218.62	-296.45
Employee Benefit Expenses	608.64	552.21	496.57	445.14	401.88
Finance Costs	146.83	150.82	145.70	87.79	65.92
Depreciation And Amortisation Expenses	358.79	345.01	300.58	235.48	196.64
Other Expenses	1,200.82	1,104.91	1,082.65	768.14	681.84
Total Expenses	4,778.27	4,558.34	4,737.97	3,745.11	3,521.41
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	503.81	301.47	1,051.43	975.41	1,274.63
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	503.81	301.47	1,051.43	975.41	1,274.63
Tax Expenses-Continued Operations
Current Tax	153.84	87.94	270.78	231.42	334.98
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-30.42	-10.17	20.27	-6.10	-16.46
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	123.42	77.77	291.05	225.32	318.52
Profit/Loss After Tax And Before ExtraOrdinary Items	380.39	223.70	760.38	750.09	956.11
Profit/Loss From Continuing Operations	380.39	223.70	760.38	750.09	956.11
Profit/Loss For The Period	380.39	223.70	760.38	750.09	956.11
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	7.06	4.15	14.14	13.97	17.85
Diluted EPS (Rs.)	7.05	4.15	14.09	13.97	17.77
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	43.13	86.18	107.47	85.86	75.04
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	60.00	40.00	100.00	100.00	100.00